In detail, these authors demonstrated, in 4T1 tumor-bearing BALB/c mice, that the combination of IL-1β (AF-401-NA) and anti-PD1 (RMP1-14) antibodies was able to induce the complete inhibition of tumor [141]. The gene discussed is IL1B; the disease is neoplasm.